Zydus Lifesciences posted strong Q3 results with revenue up 30% to Rs 6,864.5 crore, driven by consumer wellness and overseas markets. Profit growth was muted by one-time costs, while EBITDA rose 31%, reflecting scalable operations and demand across geographies.
Source :- Markets-Economic Times Read More
